Declan Noone
Impact in
- Hematology top 1%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
- Hematology 46
- Hemophilia Treatment and Research 46
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 2
- Co-authors
- Brian O’Mahony (30 shared papers)Lucia Prihodová (5 shared papers)Mark W. Skinner (15 shared papers)Flora Peyvandi (8 shared papers)Paul L. F. Giangrande (3 shared papers)David Page (13 shared papers)Karin P. M. van Galen (2 shared papers)Michelle Lavin (2 shared papers)
- Journals
- Haemophilia (29 papers)Blood (5 papers)Journal of Thrombosis and Haemostasis (2 papers)Orphanet Journal of Rare Diseases (2 papers)F1000Research (1 paper)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Declan Noone
56 papers receiving 856 citations
Peers
Comparison fields: 5 of 48
- Hematology 786
- Economics and Econometrics 58
- Genetics 37
- Health Informatics 3
- Hepatology 10
Countries citing papers authored by Declan Noone
This map shows the geographic impact of Declan Noone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Declan Noone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Declan Noone more than expected).
Fields of papers citing papers by Declan Noone
This network shows the impact of papers produced by Declan Noone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Declan Noone. The network helps show where Declan Noone may publish in the future.
Co-authors
The 25 scholars most cited alongside Declan Noone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 63 | |
| 2 | 2021 | 61 | |
| 3 | 2013 | 51 | |
| 4 | 2021 | 51 | |
| 5 | 2012 | 47 | |
| 6 | 2018 | 43 | |
| 7 | 2019 | 43 | |
| 8 | 2021 | 39 | |
| 9 | 2023 | 36 | |
| 10 | 2022 | 29 | |
| 11 | 2011 | 28 | |
| 12 | 2020 | 28 | |
| 13 | 2010 | 25 | |
| 14 | 2020 | 22 | |
| 15 | 2022 | 20 | |
| 16 | 2023 | 20 | |
| 17 | 2015 | 19 | |
| 18 | 2018 | 19 | |
| 19 | 2020 | 19 | |
| 20 | 2022 | 17 |
About Declan Noone
Declan Noone is a scholar working on Hematology, Economics and Econometrics, Hepatology, General Health Professions and Pharmacology, having authored 57 papers that have together received 907 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (46 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Health Services Management and Policy (2 papers), Hepatitis C virus research (2 papers), Pharmaceutical Economics and Policy (2 papers), Cancer survivorship and care (2 papers), Healthcare Systems and Practices (2 papers) and Musculoskeletal pain and rehabilitation (2 papers). The work is most often cited by research in Hematology (786 citations), Economics and Econometrics (58 citations), Genetics (37 citations), Health Informatics (3 citations) and Hepatology (10 citations). Declan Noone has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Brian O’Mahony, Lucia Prihodová, Mark W. Skinner, Flora Peyvandi, Paul L. F. Giangrande, David Page, Karin P. M. van Galen, Michelle Lavin, Rezan A. Kadir and Glenn F. Pierce. Their work appears in journals such as Haemophilia, Blood, Journal of Thrombosis and Haemostasis, Orphanet Journal of Rare Diseases and F1000Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.